A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Syros Pharmaceuticals Inc.’s current trading price is -34.52% away from its 52-week high, while its distance from the 52-week low is 155.96%. The stock’s price range for this time frame has been between $2.09 and $8.17. The trading volume of the company’s shares in the Healthcare reached around 0.32 million for the day, which was evidently higher than the average daily volume of 0.2 million over the last three months.
Syros Pharmaceuticals Inc.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $8.17 on 01/02/24, with the lowest value being $2.09 on 10/19/23.
How Financial Performance Impacts Market Capitalization
Syros Pharmaceuticals Inc. (SYRS) has experienced a quarterly decline of -26.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 139.15M and boasts a workforce of 68 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.76, with a change in price of +2.99. Similarly, Syros Pharmaceuticals Inc. recorded 246,355 in trading volume during the last 100 days, posting a change of +126.69%.
How SYRS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SYRS stands at 3.73. Similarly, the long-term debt-to-equity ratio is also 3.19.
SYRS Stock Stochastic Average
The raw stochastic average for Syros Pharmaceuticals Inc. over the last 50 days is presently at 7.12%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 7.27%. Further, the company’s Stochastic %K and %D values for the last 20 days were 14.35% and 18.93%, respectively.
SYRS Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -31.32%. However, over the last six months, the performance has been weaker by 34.42%. The price of SYRS decreased -25.59% over the last 30 days. And in the last five days, it has fallen by -15.62%.
